Biotech-IgG Equity Overview

  • Year Founded
  • 1996

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 5

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Biotech-IgG Equity General Information

Description

Manufacturer of advanced diagnostic instruments intended to serve the healthcare markets. The company specializes in establishing T2Dx instruments for blood analysis and is engaged in the manufacture and sale of kits and reagents, immunodiagnostics instruments, diagnostic kits and other analytical instruments, thereby enabling rapid detection of sepsis and improving patient outcomes.

Contact Information

Formerly Known As
Chemel, Biotech IgG
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Box 4211
  • 171 04 Solna
  • Sweden
+46 054-15
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Parent Company
Conquest Capital Management
Vertical(s)
Corporate Office
  • Box 4211
  • 171 04 Solna
  • Sweden
+46 054-15

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotech-IgG Equity Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biotech-IgG Equity‘s full profile, request access.

Request a free trial

Biotech-IgG Equity Patents

Biotech-IgG Equity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1787110-A1 Calibratable flow detector Inactive 25-Aug-2004
EP-1787110-A4 Calibratable flow detector Inactive 25-Aug-2004
US-20080184810-A1 Calibratable flow detector Active 25-Aug-2004
US-7780917-B2 Low molecular substances can be determined qualitatively and quantitatively with the reliably calibrated flow-through detector and that this detector can be joined in direct connection with a sample outlet e.g. liquid flow from a micro-dialysis probe, filter probe, fermenter, cell suspension Inactive 25-Aug-2004
CA-2573071-A1 Sire flow detector Inactive 08-Jul-2004 G01N27/40
To view Biotech-IgG Equity’s complete patent history, request access »

Biotech-IgG Equity Executive Team (3)

Name Title Board Seat
Johan Backman Managing Director & Board Member
Glenn Renhult Chairman
You’re viewing 2 of 3 executive team members. Get the full list »

Biotech-IgG Equity Board Members (2)

Name Representing Role Since
Biotech-IgG Equity Chairman
Biotech-IgG Equity Managing Director & Board Member
To view Biotech-IgG Equity’s complete board members history, request access »

Biotech-IgG Equity Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biotech-IgG Equity Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biotech-IgG Equity‘s full profile, request access.

Request a free trial

Biotech-IgG Equity FAQs

  • When was Biotech-IgG Equity founded?

    Biotech-IgG Equity was founded in 1996.

  • Where is Biotech-IgG Equity headquartered?

    Biotech-IgG Equity is headquartered in Solna, Sweden.

  • What is the size of Biotech-IgG Equity?

    Biotech-IgG Equity has 5 total employees.

  • What industry is Biotech-IgG Equity in?

    Biotech-IgG Equity’s primary industry is Diagnostic Equipment.

  • Is Biotech-IgG Equity a private or public company?

    Biotech-IgG Equity is a Private company.

  • What is Biotech-IgG Equity’s current revenue?

    The current revenue for Biotech-IgG Equity is .

  • Who are Biotech-IgG Equity’s investors?

    European Institute of Science has invested in Biotech-IgG Equity.

  • When was Biotech-IgG Equity acquired?

    Biotech-IgG Equity was acquired on 23-Dec-2019.

  • Who acquired Biotech-IgG Equity?

    Biotech-IgG Equity was acquired by Conquest Capital Management.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »